The miR21/10b ratio as a prognostic marker in clear cell renal cell carcinoma

European Journal of Cancer

Volumn 50, Issue 10, 2014, Pages 1758-1765

  Fritz, Helena K M ^a   Lindgren, David ^a   Ljungberg, Börje ^b   Axelson, Håkan ^a   Dahlbäck, Björn ^a  

^a LUND UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Biomarker; Cancer; Clear cell renal cell carcinoma; Kidney cancer; microRNA; miRNA; Prognosis; RCC; Renal cancer

Indexed keywords

MICRORNA 101; MICRORNA 10B; MICRORNA 21; MICRORNA 223;

ADULT; ADVERSE OUTCOME; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE SPECIFIC SURVIVAL; FEMALE; HIGH RISK PATIENT; HUMAN; KIDNEY CARCINOMA; KIDNEY CORTEX; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE;

BIOMARKER; CANCER; CLEAR CELL RENAL CELL CARCINOMA; KIDNEY CANCER; MICRORNA; MIRNA; PROGNOSIS; RCC; RENAL CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; DATABASES, GENETIC; DISEASE-FREE SURVIVAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM STAGING; PHENOTYPE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84901752563     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.03.281     Document Type: Article

References (36)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
2. S. Weikert, and B. Ljungberg Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention World J Urol 28 2010 247 252
3. A. Lopez-Beltran, M. Scarpelli, R. Montironi, and Z. Kirkali 2004 WHO classification of the renal tumors of the adults Eur Urol 49 2006 798 805
4. A. Lopez-Beltran, J.C. Carrasco, L. Cheng, M. Scarpelli, Z. Kirkali, and R. Montironi 2009 update on the classification of renal epithelial tumors in adults Int J Urol 16 2009 432 443
5. I. Frank, M.L. Blute, J.C. Cheville, C.M. Lohse, A.L. Weaver, and H. Zincke An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score J Urol 168 2002 2395 2400
6. B.C. Leibovich, M.L. Blute, and J.C. Cheville et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials Cancer 97 2003 1663 1671
7. B. Escudier, T. Eisen, and C. Porta et al. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 23 Suppl. 7 2012 vii65 71
8. H.T. Cohen, and F.J. McGovern Renal-cell carcinoma N Engl J Med 353 2005 2477 2490
9. B. Ljungberg, N.C. Cowan, and D.C. Hanbury et al. EAU guidelines on renal cell carcinoma: the 2010 update Eur Urol 58 2010 398 406
10. G. Novara, V. Ficarra, and A. Antonelli et al. Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? Eur Urol 58 2010 588 595
11. M. Pichler, G.C. Hutterer, and T.F. Chromecki et al. External validation of the Leibovich prognosis score for nonmetastatic clear cell renal cell carcinoma at a single European center applying routine pathology J Urol 186 2011 1773 1777
12. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
13. B.P. Lewis, C.B. Burge, and D.P. Bartel Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 120 2005 15 20
14. D. Baek, J. Villen, C. Shin, F.D. Camargo, S.P. Gygi, and D.P. Bartel The impact of microRNAs on protein output Nature 455 2008 64 71
15. M. Selbach, B. Schwanhausser, N. Thierfelder, Z. Fang, R. Khanin, and N. Rajewsky Widespread changes in protein synthesis induced by microRNAs Nature 455 2008 58 63
16. O. Slaby, M. Redova, and A. Poprach et al. Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients Genes Chromosomes Cancer 51 2012 707 716
17. S. Osanto, Y. Qin, and H.P. Buermans et al. Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing PLoS One 7 2012 e38298
18. Z. Wotschofsky, J. Liep, and H.A. Meyer et al. Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas Int J Biol Sci 8 2012 1363 1374
19. X. Wu, L. Weng, and X. Li et al. Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis PLoS One 7 2012 e35661
20. D. Juan, G. Alexe, and T. Antes et al. Identification of a microRNA panel for clear-cell kidney cancer Urology 75 2010 835 841
21. M.S. Zaman, V. Shahryari, and G. Deng et al. Up-regulation of microRNA-21 correlates with lower kidney cancer survival PLoS One 7 2012 e31060
22. M.A. Hildebrandt, J. Gu, and J. Lin et al. Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma Oncogene 29 2010 5724 5728
23. Cancer Genome Atlas Research N Comprehensive molecular characterization of clear cell renal cell carcinoma Nature 499 2013 43 49
24. O. Larne, E. Martens-Uzunova, and Z. Hagman et al. MiQ-a novel microRNA based diagnostic and prognostic tool for prostate cancer Int J Cancer 132 2013 2867 2875
25. A.A. Hakimi, I. Ostrovnaya, and B. Reva et al. Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 Clin Cancer Res 19 2013 3259 3267
26. A. Gustafsson, D. Martuszewska, and M. Johansson et al. Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival Clin Cancer Res 15 2009 4742 4749
27. J. Vandesompele, K. De Preter, and F. Pattyn et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biol 3 2002 RESEARCH0034
28. J.W. Catto, A. Alcaraz, and A.S. Bjartell et al. MicroRNA in prostate, bladder, and kidney cancer: a systematic review Eur Urol 59 2011 671 681
29. N. Dey, F. Das, and N. Ghosh-Choudhury et al. MicroRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion PLoS One 7 2012 e37366
30. G. Gabriely, N.M. Teplyuk, and A.M. Krichevsky Context effect: microRNA-10b in cancer cell proliferation, spread and death Autophagy 7 2011 1384 1386
31. L. Ma, and R.A. Weinberg MicroRNAs in malignant progression Cell Cycle 7 2008 570 572
32. J. Heinzelmann, B. Henning, and J. Sanjmyatav et al. Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma World J Urol 29 2011 367 373
33. S.D. Selcuklu, M.T. Donoghue, and C. Spillane MiR-21 as a key regulator of oncogenic processes Biochem Soc Trans 37 2009 918 925
34. A. Zhang, Y. Liu, Y. Shen, Y. Xu, and X. Li MiR-21 modulates cell apoptosis by targeting multiple genes in renal cell carcinoma Urology 78 474 2011 e13 19
35. A. Zarjou, S. Yang, E. Abraham, A. Agarwal, and G. Liu Identification of a microRNA signature in renal fibrosis: role of miR-21 Am J Physiol Renal Physiol 301 2011 F793 801
36. D. Iliopoulos, S.A. Jaeger, H.A. Hirsch, M.L. Bulyk, and K. Struhl STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer Mol Cell 39 2010 493 506